LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 124 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $37,000 | +23.3% | 18,635 | +20.5% | 0.02% | 0.0% |
| Q1 2020 | $30,000 | -53.1% | 15,459 | 0.0% | 0.02% | -40.0% |
| Q4 2019 | $64,000 | -22.9% | 15,459 | -43.9% | 0.02% | -19.4% |
| Q3 2019 | $83,000 | -52.0% | 27,538 | 0.0% | 0.03% | -50.8% |
| Q2 2019 | $173,000 | +10.9% | 27,538 | -2.0% | 0.06% | +5.0% |
| Q1 2019 | $156,000 | -25.7% | 28,100 | +42.8% | 0.06% | -20.0% |
| Q3 2018 | $210,000 | -11.0% | 19,684 | 0.0% | 0.08% | -7.4% |
| Q2 2018 | $236,000 | -35.5% | 19,684 | -53.9% | 0.08% | -35.2% |
| Q1 2018 | $366,000 | +136.1% | 42,709 | +171.4% | 0.12% | +135.8% |
| Q4 2017 | $155,000 | -20.9% | 15,736 | -1.2% | 0.05% | -25.4% |
| Q3 2017 | $196,000 | -25.2% | 15,926 | 0.0% | 0.07% | -23.7% |
| Q2 2017 | $262,000 | -3.7% | 15,926 | -30.0% | 0.09% | -21.2% |
| Q1 2016 | $272,000 | – | 22,753 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |